13 June 2018 01:30 - 02:30pm - Australia/Sydney
The news in "artificial blood” is that two research groups have transformed adult cells into stem cells that can regenerate both themselves and all the cellular components of blood. This development has been described as "the holy grail”, and offers a potential treatment for those who need bone marrow transplants and can't find appropriate donors. This is a significant milestone in regenerative medicine, and if taken to its logical conclusion, may reduce or eliminate the need for bone marrow transplants as well as red cell and platelet donations. However, these reports are a long way (many years) from clinical application in humans at present. The current state of play is presented.
| Presenter: | Dr Rebecca Griffiths, Senior Post Doctoral Scientist - Stem Cell Ageing and Regenerative Engineering Australian Institute for Bioengineering and Nanotechnology, The University of Queensland. |
|---|
9 May 2018 Topic will be prerecorded and made available at 1:30PM EST
In good news for Australian Defence Force personnel, and potentially many civilian patients in the future, after five years of intense research and development, results for the Blood Service's Frozen Blood Project are heating up. This exciting work extends the shelf-life of blood components up to 10 years by adapting and developing blood freezing technologies, cryopreservation. Advances it this area are presented.
| Presenter: | Dr Lacey Johnson, Principal Research Fellow, Australian Red Cross Blood Service. |
|---|
22 November 2017 01:30 - 02:00pm - Australia/Sydney
This session provides an introduction to ABO subgroups: what they are, how we detect them and their significance in transfusion.
Mr Simon Benson is a Senior Transfusion Scientist at the Blood Service.
20 September 2017 01:30pm - 02:00pm Australia/Sydney
This session will include an overview of the challenges faced by a transfusion laboratory as they perform pre-transfusion testing to find compatible blood for multiple myeloma patients undergoing Daratumumab therapy and how these issues can be resolved.
Ms Kerman Buhariwala is a Medical Scientist in Clinical Services and Research at the Blood Service.
23 August 2017 01:30pm - 02:00pm - Australia/Sydney
This session provides an overview of the testing provided as part of the pretransfusion testing process.
Ms Helen Stathopoulos is a Senior Transfusion Scientist at the Blood Service.
Transfusion Update Conference 2017: Day 2 - Friday 28 April 2017
Presenter: Professor Tor Hervig, Chief Medical Officer, Blood Bank, Haukeland University Hospital and Professor, Gades Institute, University of Bergen, Norway
Transfusion Update Conference 2017: Day 2 - Friday 28 April 2017
Presenter: Dr Denese Marks, National Research and Development Leader, Product Development and Storage, Australian Red Cross Blood Service, Australia.
Transfusion Update Conference 2017: Day 2 - Friday 28 April 2017
Presenter: Dr James AuBuchon, President and Chief Executive Officer, Bloodworks Northwest and Professor of Medicine (Hematology) and Laboratory Medicine, Univeristy of Washington, United States of America
Transfusion Update Conference 2017: Day 2 - Friday 28 April 2017
Presenter: Dr Richard Kaufman, Associate Professor of Pathology, Harvard Medical School and Medical Director of Adult Transfusion Medicine Service, Brigham and Women's Hospital, United States of America.
19 April 2017 01:30pm - 02:00pm - Australia/Sydney
This session provides an overview of the day to day processes and challenges faced by a transfusion laboratory servicing an obstetric and neonatal/paediatric hospital environment.
Mr Arthur Joyce is the Blood Bank Manager at Mater Health Services in Brisbane.
24 August 2016 01:30pm - 02:00pm - Australia/Sydney
Managing patients with clinically significant antibodies poses some unique challenges for their transfusion support, clinical management and their longer term care. The session explores a case involving a patient with such complex transfusion requirements.
Shu Min Wong, Haematology Registrar, Blood Service Registrar
11 May 2016 01:30pm - 02:30pm - Australia/Brisbane
Gene Sequencing technology and developments in microarray platforms are already having an impact on the ability to provide compatible matched red cells for patients in the 21st century. This session outlines the technology changes going forward as well as solving some mysteries from the past and assisting in the management of clinical challenges of today.
| Presenters: | Jenny Morrison, Scientist, Red Cell Reference, Blood Service. |
|---|---|
| Dr Elizna Schoeman, Senior Research Assistant, Research and Development, Blood Service. | |
| Dr Catherine Hyland, Principal Research Fellow, Research and Development, Blood Service. |
27 April 2016 01:30pm - 02:00pm - Australia/Sydney
This session explores the clinically significant non ABO red cell blood group systems; their investigation, classification and clinical significance.
Professor Robert Flower is a Transfusion Science Research Program Leader at the Blood Service.
17 Oct 2015 01:30pm - 03:00pm - Australia/Adelaide
An overview of emerging infectious diseases and their implications for transfusion, comparing the international perspective with the Australian experience. We will also look at the dilemma faced by the transfusion sector in balancing funding of infectious disease testing and the providing a safe and sufficient blood supply.
| Presenter: | Dr Michael Busch, Adjunct Professor, Department of Laboratory Medicine, University of California San Francisco; Director, Blood Systems Research Institute; Senior Vice President, Research/Scientific Affairs, Blood Systems Inc. |
|---|---|
| Dr Clive Seed, Senior Blood Safety Analyst, Australian Red Cross Blood Service |
9 Sep 2015 01:30pm - 03:00pm - Australia/Brisbane
Sheep provide a model for studying integrative physiology in biomedical research. The sheep model allows exploration of a range of transfusion-related research topics such as transfusion related acute lung injury (TRALI), septic shock and resuscitation after trauma. Speakers will include a research and clinical perspective of their topics.
| Presenters: | Dr John-Paul Tung, Research Fellow, Australian Red Cross Blood Service |
|---|---|
| Dr Elissa Milford, Australian Defence Force, University of Queensland, Critical Care Research Group, Prince Charles Hospital | |
| Dr Liam Byrne, Intensive Care Research, Canberra Hospital |
Watch this presentation by Ms Bridget Ady and Dr Phillip Mondy (11 June 2014), providing an update on the TRANSFUSE study. This investigates whether transfusion of fresh red cells reduces mortality in critically ill patients. In addition the red cell storage lesion is discussed.
Ms Ady is the TRANSFUE-RCT project manager and Dr Mondy is a Transfusion Medicine Specialist and Haematologist at the Blood Service and Consultant Haematologist at the Royal Prince Alfred Hospital.